Found: 10
Select item for more details and to access through your institution.
Doxorubicin, vinblastine, dacarbazine and lenalidomide for older Hodgkin lymphoma patients: final results of a German Hodgkin Study Group (GHSG) phase‐I trial.
- Published in:
- Angewandte Chemie, 2019, v. 131, n. 15, p. 42, doi. 10.1111/bjh.15741
- By:
- Publication type:
- Article
Low B‐cell content is associated with a CD73‐low tumour microenvironment and unfavourable prognosis in classic Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 6, p. 1097, doi. 10.1111/bjh.18762
- By:
- Publication type:
- Article
Reinduction therapy with everolimus in combination with dexamethasone, high‐dose cytarabin and cisplatinum in patients with relapsed or refractory classical Hodgkin lymphoma: an experimental phase I/II multicentre trial of the German Hodgkin Study Group (GHSG HD‐R3i)
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 3, p. 606, doi. 10.1111/bjh.17878
- By:
- Publication type:
- Article
Doxorubicin, vinblastine, dacarbazine and lenalidomide for older Hodgkin lymphoma patients: final results of a German Hodgkin Study Group (GHSG) phase‐I trial.
- Published in:
- British Journal of Haematology, 2019, v. 185, n. 1, p. 42, doi. 10.1111/bjh.15741
- By:
- Publication type:
- Article
Impact of centralized diagnostic review on quality of initial staging in Hodgkin lymphoma: experience of the German Hodgkin Study Group.
- Published in:
- British Journal of Haematology, 2015, v. 171, n. 4, p. 547, doi. 10.1111/bjh.13646
- By:
- Publication type:
- Article
Histopathological features and their prognostic impact in nodular lymphocyte-predominant Hodgkin lymphoma - a matched pair analysis from the German Hodgkin Study Group (GHSG).
- Published in:
- British Journal of Haematology, 2014, v. 167, n. 2, p. 238, doi. 10.1111/bjh.12997
- By:
- Publication type:
- Article
Histopathological features and their prognostic impact in nodular lymphocyte-predominant Hodgkin lymphoma – a matched pair analysis from the German Hodgkin Study Group (GHSG)
- Published in:
- British Journal of Haematology, 2014, v. 165, n. 5, p. 1, doi. 10.1111/bjh.12997
- By:
- Publication type:
- Article
Phase II study of fixed‐duration single‐agent ibrutinib in relapsed nodular lymphocyte‐predominant Hodgkin lymphoma: A report from the German Hodgkin Study Group.
- Published in:
- Hematological Oncology, 2022, v. 40, n. 4, p. 801, doi. 10.1002/hon.2986
- By:
- Publication type:
- Article
The time to relapse correlates with the histopathological growth pattern in nodular lymphocyte predominant Hodgkin lymphoma.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 11, p. 1208, doi. 10.1002/ajh.25607
- By:
- Publication type:
- Article
Baseline serum TARC levels predict therapy outcome in patients with Hodgkin lymphoma.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 2, p. 113, doi. 10.1002/ajh.23361
- By:
- Publication type:
- Article